Chem. J. Chinese Universities ›› 2010, Vol. 31 ›› Issue (9): 1753.

• Articles • Previous Articles     Next Articles

Design, Synthesis and Activity Evaluation of 9-Substituted-2-amino-6-guanidinopurines as Acrosin Inhibitors

ZHANG Xiao-Meng, ZHU Ju, LIU Xue-Fei, SHENG Chun-Quan, ZHENG Can-Hui, FU Xiao-Dan, SONG Yun-Long, ZHOU You-Jun*, LÜ Jia-Guo*   

  1. Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
  • Received:2010-01-21 Online:2010-09-10 Published:2010-09-10
  • Contact: Lü Jia-Guo. E-mail: ljg20060508@yahoo.com.cn; ZHOU You-Jun. E-mail: Zhouyoujun2005@yahoo.com.cn
  • Supported by:

    上海市计划生育委员会科研基金(批准号: 2007JG02)及上海市重点学科建设项目基金(批准号: B906)资助.

Abstract: Acrosin, a trypsin-like endoprotease, present in the acrosome of spermatozoa, is a promising target for contraceptive agents. Based on the previous homology modeling and the analysis of the properties of the activity site of human acrosin, a series of 9-substituted-2-amino-6-guanidinopurines were designed and synthesized on a scaffold represented by KF950. The structrues of all the title compounds were comfirmed by 1H NMR, MS, IR and elemental analysis. Intermediate 5m was determined by single crystal X-ray diffraction analysis. The inhibitory activities against acrosin of all target compounds were tested in vitro and all of them exhibited much more inhibitory activities against acrosin, respectively, with positive control, TLCK. Compound 6z exhibited similar inhibitory activities against KF950. The activity results indicate the following structure-activity relationship(SAR): (1) the introduction of disubstituded groups at aryl moiety caused better inhibitory activities than those of monosubstituded groups; (2) lower inhibitory activities were also observed for the compounds bearing electron-donating groups(6q—6w)comparing with the compounds bearing withdrawing electron groups(6b—6p); (3) long chain substituents at 9-position(6x—6z) can enhance the inhibitory activity signficantly.

Key words: Acrosin inhibitor, Activity site, Guanidinopurine, Crystal structure, Inhibitor activity

TrendMD: